[(2R)-1-[(1R)-1-PHENYLETHYL]AZETIDIN-2-YL]METHANOL, 95.0%, 250mg

tert-Butyl 4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate, 95.0%, 25g

Methyl 2-amino-5-bromobenzoate, 98.0%, 100g

Éster isopropílico del ácido mirístico, mínimo 92 %, extrapuro, 2,5 l, envase de vidrio

Vinyl Chloroacetate (stabilized with MEHQ)>99.0%(GC)25g

2,5-dichloro-2'-thiomorpholinomethyl benzophenone, 97.0%, 1g

N,N,N',N'',N''-Pentakis(2-hydroxypropyl)diethylenetriamine>95.0%(T)100g

ethyl 5-amino-1-(3-chlorobenzyl)-1H-pyrazole-4-carboxylate, 95.0%, 1g

5-Hydroxy-2-methyl-1H-indole-3-carbaldehyde, 95+%, 1g

N-HYDROXY-4-IODOBENZAMIDE, 95%, 250mg

1,4-Dibromo-2-(difluoromethoxy)benzene, 95.0%, 5g

2,3-Dihydroxypropyl 2-((7-chloroquinolin-4-yl)amino)benzoate, 95.0%, 100mg

Potassium 2-methoxy-2-oxoacetate, 97.0%, 1g